◼ Archived
Health
HIV prevention drug hailed as breakthrough, but who gets access?
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
4 trends tracked about this subject — the full history, oldest to newest below.
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Analysis of South Africa's first Lenacapavir roll-out data emerges alongside global coverage of the twice-yearly HIV prevention shot.
Merck is establishing global access and licensing frameworks for the world's first monthly oral HIV prevention pill ahead of its official approval.
Global HIV progress unravels as funding cuts and laws threaten a resurgence of the epidemic, warn UN officials and activists.